News
One of the strengths of Redoxis AB has always been the people behind the science. I'm therefore very happy to share that Filip Fredlund has stepped into the role of Head…
Nina Woodworth, Chief Business Officer at Redoxis, will attend Nordic Life Science Days in Stockholm on 8 September 2026. Redoxis supports biotech and pharmaceutical companies with tailored preclinical studies in…
Over the past few years, we've continuously expanded Redoxis AB—not only by growing our team, but by broadening both the scientific expertise and technologies we can offer our customers. As…
Redoxis is pleased to have joined the KKS-Synergi21 research project Drug discovery targeting inflammation – novel therapeutic aspects on vascular inflammation, thrombosis and breast cancer. The project is led by Karin H…
Next week, Nina Woodworth and Malin Hultqvist Davidsson will be heading to San Diego for BIO International. For us, BIO offers an opportunity to reconnect with partners, meet new people,…
